Lymphocyte subpopulations and hematologic variables in dogs with congestive heart failure

Journal of Veterinary Internal Medicine

Volumn 18, Issue 4, 2004, Pages 505-509

  Farabaugh, Andrew E ^a   Freeman, Lisa M ^a   Rush, John E ^a   George, Katherine L ^b  

^a TUFTS UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

CD4; CD8; Flow cytometry; Heart disease; Hematocrit; Leukocytes

Indexed keywords

ARTICLE; BLOOD CELL COUNT; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HEMATOCRIT; HEMOGLOBIN DETERMINATION; LEUKOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALE; NEUTROPHIL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; T LYMPHOCYTE; THROMBOCYTE COUNT; VALVULAR HEART DISEASE;

ANIMALS; BLOOD CELL COUNT; CASE-CONTROL STUDIES; DOG DISEASES; DOGS; FEMALE; FLOW CYTOMETRY; HEART FAILURE, CONGESTIVE; LYMPHOCYTE SUBSETS; MALE;

ANIMALIA; CANIS FAMILIARIS; STAPHYLOCOCCUS PHAGE 3A;

EID: 4243128184     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2004)18<505:LSAHVI>2.0.CO;2     Document Type: Article

References (42)

1. Levine B, Kalman J, Mayer L, et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;323:236-241.
2. McMurray J, Abdullah I, Dargie HJ, Shapiro D. Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. Br Heart J 1991;66:356-358.
3. Freeman LM, Rush JE, Kehayias JJ, et al. Nutritional alterations and the effect of fish oil supplementation in dogs with heart failure. J Vet Intern Med 1998;12:440-448.
4. Meurs KM, Fox PR, Miller MW, et al. Plasma concentrations of tumor necrosis factor-alpha in cats with congestive heart failure. Am J Vet Res 2002;63:640-642.
5. Acanfora D, Gheorghiade M, Trojano L, et al. Relative lymphocyte count: A prognostic indicator of mortality in elderly patients with congestive heart failure. Am Heart J 2001;142:167-173.
6. Anand I, Florea V, Glazer R, et al. Baseline percent lymphocyte count and changes in percent lymphocyte count over time and subsequent mortality and morbidity in Val-HeFT. J Cardiac Failure 2002;8(Suppl):S54.
7. Ommen SR, Hodge DO, Rodeheffer RJ, et al. Predictive power of the relative lymphocyte concentration in patients with advanced heart failure. Circulation 1998;97:19-22.
8. Yokoi M, Sawada T, Yamano T, et al. Relationship between lymphocyte count and long-term outcome in patients with dilated cardiomyopathy presenting in acute progressive heart failure. J Cardiac Failure 1999;5:69.
9. Hwang S, Harris TJ, Wilson NW, Maisel AS. Immune function in patients with chronic stable congestive heart failure. Am Heart J 1993;125:1651-1658.
10. Fowles RE, Bieber CP, Stinson EB. Defective in vitro suppressor cell function in idiopathic congestive cardiomyopathy. Circ 1979;59:483-491.
11. Eckstein R, Mempel W, Bolte HD. Reduced suppressor cell activity in congestive cardiomyopathy and in myocarditis. Circ 1982;65:1224-1229.
12. Sanderson JE, Koech D, Iha D, et al. T-lymphocyte subsets in idiopathic cardiomyopathy. Am J Cardiol 1985;55:755-758.
13. Franceschini R, Messina V, Petillo A, et al. Humoral immunity and lymphocyte subpopulations in patients with dilated cardiomyopathy. Int J Cardiol 1985;8:113-123.
14. Takamoto T, Hori Y, Yokoyama M, et al. Lymphocyte subsets in patients with dilated cardiomyopathy and perimyocarditis. J Clin Lab Immunol 1986;19:113-116.
15. Huber KC, Gersh BJ, Sugrue DD, et al. T-lymphocyte subsets in patients with idiopathic cardiomyopathy. Arch Immunol Ther Exp 1991;39:33-40.
16. Maisel AS, Knowlton KU, Fowler P, et al. Adrenergic control of circulating lymphocyte subpopulations. Effects of congestive heart failure, dynamic exercise, and terbutaline treatment. J Clin Inv 1990;85:462-467.
17. Kanda T, Yokoyama T, Ohshima S, et al. T-lymphocyte subsets as noninvasive markers of cardiomyopathy. Clin Cardiol 1990;13:617-622.
18. Maruta M, Takenaka K, Takabe H, et al. Humoral immunity and lymphocyte subsets in patients with dilated cardiomyopathy. Japan J Clin Pathol 1991;39:824-828.
19. Smalcelj A, Durakovic Z, Batinic D, et al. Relation between helper and suppressive/cytotoxic T lymphocytes in the peripheral blood in patients with dilated cardiomyopathy. Acta Med Yugoslavica 1991;45:3-13.
20. Bozkurt A, Canataroglu A, Cetiner S, et al. Lymphocyte subsets in patients with idiopathic dilated cardiomyopathy. Ana Kar Der 2001;1:98-100.
21. Koga Y, Miyazaki Y, Toshima H, et al. Lymphocyte subsets in patients with acute myopericarditis, arrhythmias and dilated cardiomyopathy. Jpn Circ J 1989;53:78-86.
22. Yamakawa K, Fukuta S, Yoshinaga T, et al. Study on lymphocyte subsets and NK cell function in patients with dilated cardiomyopathy. Jpn Circ J 1986;50:1259-1263.
23. Grzelak I, Lukomska B, Sadowsky-Szablisty D, et al. Immunophenotypic and functional characterization of peripheral blood mononuclear cell populations in patients with dilated cardiomyopathy. Arch Immunol Ther Exp 1991;39:330-340.
24. Anderson JL, Carlquist JF, Higashikubo R. Quantification of lymphocyte subsets by immunofluorescence flow cytometry in idiopathic dilated cardiomyopathy. Am J Cardiol 1985;55:1550-1554.
25. Borgarelli M, Zini E, D'Agnolo G, et al. A retrospective review of the clinical presentation, survival, and lymphocytic immunotype in German Shepherds with primary mitral insufficiency. Proceedings of the 20th Annual ACVIM Forum, Dallas TX, 2002:106-107.
26. Klappacher G, Mehrabi M, Plesch K, et al. Serum-soluble CD4 as clinical and immunological marker in patients with dilated cardiomyopathy. Immunol Lett 1993;38:103-109.
27. Kyne L, Hausdorff J, Knight E, et al. Neutrophilia and congestive heart failure after acute myocardial infarction. Am Heart J 2000;139:94-100.
28. Horwich TB, Fonarow GC, Hamilton MA, et al. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002;39:1780-1786.
29. Kosiborod M, Smith GL, Radford MJ, et al. The prognostic importance of anemia in patients with heart failure. Am J Med 2003;114:112-119.
30. Tanner H, Moschovitis G, Kuster G, et al. The prevalence of anemia in chronic heart failure. Int J Cardiol 2002;86:115-121.
31. Mozaffarian D, Nye R, Levy W. Anemia predicts mortality in severe heart failure. The prospective randomized amlodipine survival evaluation (PRAISE). J Am Coll Cardiol 2003;41:1933-1939.
32. McClellan W, Flanders W, Langston R, et al. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population based study. J Am Soc Nephrol 2002;13:1928-1936.
33. Ezekowitz J, McAlister F, Armstrong P. Anemia is common in heart failure and is associated with poor outcome: Insights from a cohort of 12,065 patients with new-onset heart failure. Circulation 2003;107:223-225.
34. Stevenson J, Westermann J, Liebmann P, et al. Prolonged alpha-adrenergic stimulation causes changes in leukocyte distribution and lymphocyte apoptosis in the rat. J Neuroimmunol 2001;120:50-57.
35. Silverberg D, Wexler D, Sheps D, et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol 2001;37:1775-1780.
36. Olsen LH, Kristensen AT, Haggstrom J, et al. Increased platelet aggregation response in Cavalier King Charles Spaniels with mitral valve prolapse. J Vet Intern Med 2001;15:209-216.
37. Smedile LE, Houston DM, Taylor SM, et al. Idiopathic, asymptomatic thrombocytopenia in Cavalier King Charles spaniels: 11 cases (1983-1993). J Am Anim Hosp Assoc 1997;33:411-415.
38. Pedersen HD, Haggstrom J, Olsen LH, et al. Idiopathic asymptomatic thrombocytopenia in Cavalier King Charles Spaniels is an autosomal recessive trait. J Vet Intern Med 2002;16:169-173.
39. Tanaka R, Yamane Y. Platelet aggregation in dogs with mitral valve regurgitation. Am J Vet Res 2000;61:1248-1251.
40. Moore PF, Rossitto PV, Danilenko DM, et al. Monoclonal antibodies specific for canine CD4 and CD8 define functional T-lymphocyte subsets and high-density expression of CD4 by canine neutrophils. Tissue Antigens 1992;40:75-85.
41. Cobbold S, Metcalfe S. Monoclonal antibodies that define canine homologues of human CD antigens: Summary of the First International Canine Leukocyte Antigen Workshop (CLAW). Tissue Antigens 1994;43:137-154.
42. Byrne KM, Kim HW, Chew BP, et al. A standardized gating technique for the generation of flow cytometry data for normal canine and normal feline blood lymphocytes. Vet Immunol Immunopathol 2000;73:167-182.